Ixoreal Biomed, the developer of the specialized KSM-66 Ashwagandha extract, has announced that its clinically studied ingredient is being incorporated into a new wellness product from the pet brand Boops Pets. The innovation is a Calming and Stress Relief supplement formulated specifically for dogs and designed to address the growing prevalence of fear and anxiety in canines.
Boops Pets leverages KSM-66 Ashwagandha, which is distinguished as the only ashwagandha extract on the market backed by clinical research and a significant number of certifications pertaining to safety and manufacturing quality. This adaptogenic herb is recognized for its ability to help regulate cortisol — the primary stress hormone — thereby supporting a healthy response to environmental triggers. The supplement aims to promote a state of calmness in dogs, helping them cope more effectively with common stressors such as loud noises, travel, or periods of separation from their owners.
Clinically Studied Calming Ingredients
Boops Pets is Using Ixoreal Biomed's Ingredient
Trend Themes
-
Adaptogenic Pet Supplements — Integration of adaptogens like clinically studied Ashwagandha into dog supplements signals the emergence of ingredient-driven calming products that bridge human and pet wellness formulations.
-
Clinically Validated Ingredient Adoption — Growing use of ingredients backed by human clinical data points to elevated consumer expectations for efficacy and third-party certifications in the pet product aisle.
-
Humanization of Pet Health — Rising demand for human-grade safety and research standards in pet care indicates a shift toward premium, science-forward offerings that mirror owner healthcare trends.
Industry Implications
-
Pet Nutraceuticals — Formulation of targeted supplements for stress and anxiety in pets presents opportunities for differentiated dosage forms, tailored delivery, and evidence-focused positioning.
-
Veterinary Care Services — Veterinary clinics and behaviorists incorporating clinically supported nutraceuticals alongside treatment plans could reshape preventive and integrative animal care models.
-
Functional Ingredient Suppliers — Suppliers of clinically validated botanical extracts are positioned to expand into animal-specific lines and certification pathways that meet stringent manufacturing and safety requirements.